Searchable abstracts of presentations at key conferences in endocrinology

ea0016p702 | Thyroid | ECE2008

The outcome of radioiodine therapy of hyperthyroidism: comparison of patients with a toxic nodular goiter and with Graves' disease

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Szymanek Bozena

Introduction: Hyperthyroidism is one of frequently encountered clinical syndromes appearing in about 2% of adult population. The aim of this study was to evaluate the efficacy of radioiodine treatment in relation to the form of hyperthyroidism.Material and methods: The study investigated 300 patients: 150 with Graves’ disease and 150 with a toxic adenoma goiter (109 with a solitary nodule and 41 with a multinodular goiter). In all the cases, the est...

ea0056p830 | Pituitary - Clinical | ECE2018

A rare case of acromegaly with normal IGF-1, severe chronic congestive heart failure, and impaired glucose tolerance

Kurowska Maria , Malicka Joanna , Zwolak Agnieszka , Tarach Jerzy S

Introduction: Acromegaly with normal IGF-1level is rarely diagnosed and is difficult to recognize. In acromegalic pa-tients with poorly controlled diabetes, malnutrition, hepatic injury, hepatic congestion due to heart fail-ure, inflammatory diseases, renal dysfunction, and malignant neoplasm, IGF-1 synthesis is inhibited and thus in such cases normal IGF-1 levels may be observed. The aim of the study is to present a rare case of a patient with acromegaly and normal IGF-1 leve...

ea0090p464 | Reproductive and Developmental Endocrinology | ECE2023

Visfatin expression and regulation by E2, P4, hCG and insulin in human placental cells

Dawid Monika , Kurowska Patrycja , Pawlicki Piotr , Kotula-Balak Małgorzata , Milewicz Tomasz , Rak Agnieszka

Introduction: Visfatin belongs to adipokines, i.e. hormones produced mainly by adipose tissue; its expression and role have been described in many organs, where it regulates energy metabolism, insulin resistance and inflammatory reactions. Moreover, the level of visfatin changes during pregnancy and in obese women and those with obesity related pregnancy pathologies: preeclampsia (PE), gestational diabetes (GDM) or intrauterine growth restriction (IUGR) its level increases. Th...

ea0090ep865 | Pituitary and Neuroendocrinology | ECE2023

Asprosin, a novel adipokine, in the mouse hypothalamus: expression and in vitro effect on GT1-7 cells proliferation and GnRH secretion. Preliminary data

Wachowska Dominika , Respekta Natalia , Kurowska Patrycja , Błasiak Anna , Dupont Joelle , Rak Agnieszka

Introduction: Asprosin, a novel adipokine, is a circulating hormone mainly secreted by white adipose tissue. Asprosin is encoded by the penultimate 2 exons of the fibrillin 1 (FBN1) gene. Protein product of FBN1 is profibrillin-1, which undergoes a proteolytic cleavage by furin enzyme to produce mature fibrillin-1 and asprosin. Literature data indicated that asprosin is involved in the development of diabetes, obesity, cardiomyopathy, cancer, and polycystic o...

ea0041ep250 | Clinical case reports - Pituitary/Adrenal | ECE2016

Capecitabine and temozolomide (CAPTEM) treatment of atypical macrocorticotropinoma in a patient with Nelson’s syndrome

Kurowska Maria , Malicka Joanna , Tarach Jerzy S , Zielinski Grzegorz , Maksymowicz Maria

Introduction: Atypical pituitary adenomas are often characterized by rapid growth and massive invasion of the surrounding structures. Usually, they are associated with poor prognosis and high recurrence rate due to resistance to conventional therapies. When surgery and radiation are ineffective, alternative therapies remain the last line treatment. Lately, a novel chemotherapy with capecitabine and temozolomide was proposed as a highly effective and extending the life of the p...

ea0041ep316 | Clinical case reports - Pituitary/Adrenal | ECE2016

Adrenal medullary hyperplasia recognized initially as incydentaloma

Kurowska Maria , Malicka Joanna , Otto Maciej , Tarach Jerzy S. , Lewicki Marcin

Introduction: Adrenal medullary hyperplasia (AMH) is a rare syndrome of catecholamine excess. Adrenal overgrowth is usually bilateral. Due to similar clinical signs, laboratory results and radiological adrenal picture, AMH can be misdiagnosed as pheochromocytoma. The only method that allows determining a proper diagnosis of AMH is pathologic examination. It is regarded as a precursor of pheochromocytoma and has been reported as a component of MEN2.Aim: T...

ea0041ep355 | Clinical case reports - Thyroid/Others | ECE2016

Amiodarone - induced type 2 thyrotoxicosis in patient with ESRD treated with hemodialysis

Kurowska Maria , Malicka Joanna , Bober-Palak Ewa , Lewicki Marcin , Tarach Jerzy S.

Introduction: Type 2 amiodarone-induced thyrotoxicosis (AIT2), resulting from the release of thyroid hormones, is a rarer form of side effect of this drug. Treatment of thyrotoxicosis in patients with end stage renal disease (ESRD) is difficult because hemodialysis alters renal clearance of drugs and iodine, may impact the results of assessment and treatment and can increase the medical instability of patients.Aim: The aim was to present the difficulties...

ea0041ep944 | Pituitary - Clinical | ECE2016

The prevalence of metabolic syndrome in adult patients with long-standing hypopituitarism who receive adequate supplemental therapy

Zwolak Agnieszka , Swirska Joanna , Dudzinska Marta , Kurowska Maria , Daniluk Jadwiga , Tarach Jerzy S

Introduction: Hypopituitarism is characterized by the absence of pituitary hormones. Depending on what pituitary hormones are missing and what is the etiology of hypopituitarism, its clinical manifestation varies. Apart from evident symptoms and signs of hypopituitarism due to hormonal insufficiencies, several studies reveal that long-standing hypopituitarism, including particularly absence of GH, is related to higher risk of metabolic syndrome.Objective...

ea0041ep1069 | Thyroid (non-cancer) | ECE2016

The efficacy of Radioiodine Therapy in Patients with Graves’ Disease

Dabrowska Anna , Kijek Jolanta , Tarach Jerzy , Torun-Jurkowska Anna , Chrapko Beata , Kurowska Maria

Introduction: Radioiodine (RAI) has been used for the treatment of Graves’ hyperthyroidism since 1940s. It is relatively safe and considered as one of the definitive therapies. Achievement of hypothyroidism or euthyroidism is defined as a successful therapy.Methods: The study was conducted in 366 patients (80.60% of women) with Graves’ disease (GD), aged 46.76±13.52 years. We analyzed retrospectively hormonal and imaging findings (scintigr...

ea0041ep1081 | Thyroid (non-cancer) | ECE2016

The efficacy of radioiodine therapy in patients with hyperfunctioning thyroid nodules

Dabrowska Anna , Kijek Jolanta , Tarach Jerzy , Torun-Jurkowska Anna , Chrapko Beata , Kurowska Maria

Introduction: Radioiodine (RAI) is used as a definitive therapy of hyperthyroidism due to toxic adenoma (TA) as well as toxic multinodular goiter (TMG). Achievement of hypothyroidism or euthyroidism is defined as a successful therapy.Methods: The study was conducted in 666 patients – 484 with TA and 182 with TMG (85.58% of women), aged 56.19±13.88 years. We analyzed retrospectively hormonal and imaging findings (scintigraphy, ultrasonography), ...